We also performed a differentially expressed gene analysis of the GSE181574 dataset, which contains 105 core needle biopsy samples before breast cancer treatment, including 36 HR−/HER2+ and 69 HR+/HER2+ cases. Here, ERBB2 is linked to breast carcinoma.